Servier’s Emi-Le Earns FDA Breakthrough Status
BOSTON, May 12, 2026 Servier has announced that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Therapy...
Alzheimer’s Disease Autoimmune Disease Bio-Pharma biologics biopharma biopharma innovation Biotechnology Bispecific Antibody cancer therapy Cell Therapy Clinical Development Clinical Research clinical trial clinical trials Digital Health drug development FDA fda approval FDA clearance GCP Gene Therapy Immuno-Oncology immunology Immunotherapy Medical Device Medical Devices MedTech medtech innovation Monoclonal Antibody Neurodegenerative Disease Oncology oncology innovation Ophthalmology Orphan Drug orphan drug designation Phase 2 Trial Phase 3 trial Precision Medicine Precision Oncology rare disease rare diseases Regenerative Medicine regulatory approval regulatory compliance targeted therapy
BOSTON, May 12, 2026 Servier has announced that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Therapy...
OVERLAND PARK, Kan., and BOULDER, Colo., May 12, 2026 Hill’s Pet Nutrition and Bond Pet Foods have announced a...
